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for the younger patients. A smaller dose of fentanyl was administered to the elderly patients because we were concerned that larger doses might not be tolerated clinically. Arterial plasma samples were obtained before infusion, and at 1, 
SUMMARY
The pharmacokinetics of fentanyl were determined in seven elderly (71-82 yr) mean residence time (FD SS /C7). In addition, for each patient, we calculated the plasma concentration of fentanyl per ug kg" 1 administered at each sampling time. Mean values for the two age groups were compared using Student's t test for unpaired data [6] ; P < 0.05 was considered significant. Fentanyl concentration per ug kg" 1 administered was higher in the elderly than in the younger patients at 2 min (7.73 + 3.14 v. 4.54+1.83 ng ml" 1 (mean + SD), respectively) and at 4 min after the start of infusion (3.26 ± 1.44 v. 1.78 ±0.72 ng ml" 1 , respectively) ( fig. 1 ). Concentrations at all other sampling times were similar for both age groups (figs 1, 2).
Elderly patients had a smaller volume of distribution at steady-state compared with young patients (table I) .
There were no differences in Tf, Cl or mean residence time. drugs could be the explanation. In this study, we found that the pharmacokinetics of fentanyl were similar for elderly and young patients, except for a smaller volume of distribution at steady-state in the elderly. In addition, following the administration of weight-normalized doses, plasma fentanyl concentrations were similar at all times except in the period immediately following administration. Consequently, during recovery from anaesthesia; that is 120-240 min after fentanyl administration, plasma fentanyl concentrations were similar in both groups.
Physiological changes associated with ageing would be expected to influence the metabolism and distribution of fentanyl. For example, ageing decreases liver blood flow [7] . Since most of the fentanyl entering the hepatic circulation is metabolized, this decrease in liver blood flow should decrease the clearance of fentanyl. However, we found no age-related decrease in Cl. Our finding is similar to that for lignocaine [8] , another drug highly extracted by the liver, and may reflect our selection of healthy elderly subjects.
Another age-related change is a decrease in lean body mass and an increase in fat as a percentage of body weight [9] . For lipophilic drugs such as fentanyl, this should increase the volume of distribution at steady-state. In contrast, we found that VD SS for fentanyl was smaller in the elderly group. The Fb ss for another lipophilic drug, thiopentone, is similar in young and elderly subjects [10] . Thus, ageing does not necessarily increase the FD SS of lipophilic drugs. Ageing is also associated with the decrease in the volume of extracellular fluid as well as a decrease in blood flow to organs in the vessel-rich group [10] . These factors may limit the distribution of fentanyl from blood, resulting in a higher initial plasma concentration, and would explain the higher concentration of fentanyl observed in our elderly patients immediately after administration. This higher initial concentration has also been observed with thiopentone [10] and may explain the greater response of the elderly to weight-normalized doses of that drug [10] . In support of this, Homer and Stanski [10] have demonstrated that the steady-state plasma concentrations of thiopentone that produce the same degree of electroencephalographic depression are similar in young and elderly subjects. Thus, the greater response of the elderly to weightnormalized doses of thiopentone is the result of pharmacokinetic changes; that is, a higher initial plasma concentration and, because thiopentone enters the brain rapidly, presumably a higher initial brain concentration.
Fentanyl also enters the brain rapidly [11] . Consequently, higher peak plasma concentrations of fentanyl in elderly patients may result in a greater peak response, such as depression of ventilation. Within 10 min of administration of weight-normalized doses, plasma fentanyl concentrations were similar in elderly and young patients. Thus, pharmacokinetic differences could explain only differences in peak response, and not differences occurring 1-4 h after administration.
Ageing may also produce pharmacodynamic changes that explain the more profound response of elderly patients to opioids. These pharmacodynamic changes may involve either differences in drug concentrations in the brain (for example, if there were less protein binding of fentanyl in the elderly) or differences in the sensitivity of the brain. Changes in the ventilatory response with ageing have been investigated in two studies. Arunsalam and colleagues [12] obtained ventilatory measurements before and after the i.v. administration of morphine 10 mg/70 kg, to young and elderly subjects. The decreases in minute ventilation and ventilatory frequency and the increase in end-tidal PCO2 were comparable for both. However, more than half of the elderly subjects had significant episodes of apnoea or periodic breathing. In contrast, apnoea or periodic breathing occurred in fewer than 25 % of the young subjects and with a lower frequency. These results suggest that, for a comparable pharmacodynamic endpoint (increase in Pco 2 or decrease in minute ventilation), elderly subjects differ from young subjects in ventilatory pattern in response to morphine.
Peterson and co-workers [13] found that ventilatory responses to hyperoxic hypercapnia and isocapnic hypoxia were blunted approximately 50% in elderly subjects. These decreases in ventilatory response were proportional to an agerelated decrease in occlusion pressure response (the inspiratory pressure generated 100 ms after airway occlusion). Peterson and co-workers [13] concluded that the difference in the pattern of ventilation resulted from age-related changes in neuromuscular, rather than central nervous system, function.
In combination, these two studies suggest that the ventilatory response of the elderly differs both in the presence [12] and absence [13] of opioids.
Our findings differ from those of Bentley and colleagues [14] who compared the pharmacokinetics of fentanyl in four elderly women (mean age 67 yr; range 61-73 yr) and five young women (mean age 36 yr; range 29-49 yr). They found that the volume of distribution was similar for elderly and young patients (4.9 + 0.5 and 5.9 + 0.8 litre kg" 1 (mean + SEM), respectively) and that Cl was decreased markedly in the elderly patients (4.0 + 0.6 v. 15.4+1.6 ml kg" 1 min" 1 ). They obtained samples for 7 h (in contrast to 4 h in our study), and determined fentanyl concentrations by gas chromatography. Their anaesthetic technique (nitrous oxide, thiopentone and controlled ventilation) was similar to ours. Two differences in study design may explain the difference in results. First, Bentley and colleagues [14] did not measure Pco 2 . This is important because hyperventilation, and the attendant hypocarbia, are known to decrease clearance of fentanyl [15] . Second, all of their subjects (and none of ours) underwent abdominal surgery, which produces a significant decrease in hepatic blood flow [16] that may alter the clearance of fentanyl.
In summary, we found that the clearance of fentanyl was similar in elderly and younger patients, and VD SS smaller in elderly patients. Plasma concentration of fentanyl was higher in the elderly patients immediately after administration, but similar for the two age groups during the subsequent 4 h. Our results suggest that if the effects of fentanyl are more pronounced in elderly subjects, the likely pharmacokinetic explanation is the higher initial concentration.
